These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 12975761)

  • 1. Elevated plasma homocysteine as risk factor for peripheral arterial disease--what is the evidence?
    Taylor LM
    Semin Vasc Surg; 2003 Sep; 16(3):215-22. PubMed ID: 12975761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective blinded study of the relationship between plasma homocysteine and progression of symptomatic peripheral arterial disease.
    Taylor LM; Moneta GL; Sexton GJ; Schuff RA; Porter JM
    J Vasc Surg; 1999 Jan; 29(1):8-19; discussion 19-21. PubMed ID: 9925456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low circulating folate and vitamin B6 concentrations: risk factors for stroke, peripheral vascular disease, and coronary artery disease. European COMAC Group.
    Robinson K; Arheart K; Refsum H; Brattström L; Boers G; Ueland P; Rubba P; Palma-Reis R; Meleady R; Daly L; Witteman J; Graham I
    Circulation; 1998 Feb; 97(5):437-43. PubMed ID: 9490237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hyperhomocysteinemia, a risk factor for atherosclerosis: causes and effects].
    Weiss N; Pietrzik K; Keller C
    Dtsch Med Wochenschr; 1999 Sep; 124(38):1107-13. PubMed ID: 10535040
    [No Abstract]   [Full Text] [Related]  

  • 5. Homocysteine: an aetiological contributor to peripheral vascular arterial disease.
    Kuan YM; Dear AE; Grigg MJ
    ANZ J Surg; 2002 Sep; 72(9):668-71. PubMed ID: 12269921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel risk factors for peripheral arterial disease in young women.
    Bloemenkamp DG; van den Bosch MA; Mali WP; Tanis BC; Rosendaal FR; Kemmeren JM; Algra A; Visseren FL; van der Graaf Y
    Am J Med; 2002 Oct; 113(6):462-7. PubMed ID: 12427494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homocysteine lowering interventions for peripheral arterial disease and bypass grafts.
    Hansrani M; Stansby G
    Cochrane Database Syst Rev; 2002; (3):CD003285. PubMed ID: 12137685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homocysteine. The association with atherosclerotic vascular disease in older persons.
    Aronow WS
    Geriatrics; 2003 Sep; 58(9):22-4, 27-8. PubMed ID: 14518174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relation between Helicobacter pylori and atherosclerosis cannot be explained by a high homocysteine concentration.
    Bloemenkamp DG; Mali WP; Tanis BC; Rosendaal FR; van den Bosch MA; Kemmeren JM; Algra A; Visseren FL; van der Graaf Y
    Eur J Clin Invest; 2002 Aug; 32(8):549-55. PubMed ID: 12190953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Novel risk factors for atherosclerosis. A comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a) and cholesterol as predictors of peripheral arteriopathy].
    Iacoviello L; Donati MB; de Gaetano G
    Ital Heart J Suppl; 2001 Sep; 2(9):1031-3. PubMed ID: 11675827
    [No Abstract]   [Full Text] [Related]  

  • 11. Homocysteine: a new risk factor for atherosclerosis.
    Fallest-Strobl PC; Koch DD; Stein JH; McBride PE
    Am Fam Physician; 1997 Oct; 56(6):1607-12, 1615-6. PubMed ID: 9351429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homocysteine and atherosclerosis.
    Gerhard GT; Duell PB
    Curr Opin Lipidol; 1999 Oct; 10(5):417-28. PubMed ID: 10554704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homocysteine and vascular disease.
    Berwanger CS; Jeremy JY; Stansby G
    Br J Surg; 1995 Jun; 82(6):726-31. PubMed ID: 7627498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homocysteine and occlusive arterial disease.
    O'Grady H; Kelly C; Bouchier-Hayes D; Leahy A
    Br J Surg; 2002 Jul; 89(7):838-44. PubMed ID: 12081732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between plasma homocysteine and peripheral arterial disease in older persons.
    Aronow WS; Ahn C
    Coron Artery Dis; 1998; 9(1):49-50. PubMed ID: 9589191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project.
    Graham IM; Daly LE; Refsum HM; Robinson K; Brattström LE; Ueland PM; Palma-Reis RJ; Boers GH; Sheahan RG; Israelsson B; Uiterwaal CS; Meleady R; McMaster D; Verhoef P; Witteman J; Rubba P; Bellet H; Wautrecht JC; de Valk HW; Sales Lúis AC; Parrot-Rouland FM; Tan KS; Higgins I; Garcon D; Andria G
    JAMA; 1997 Jun; 277(22):1775-81. PubMed ID: 9178790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No effect of homocysteine-lowering therapy on vascular inflammation and haemostasis in peripheral arterial occlusive disease.
    Schernthaner GH; Plank C; Minar E; Bieglmayer C; Koppensteiner R; Schernthaner G
    Eur J Clin Invest; 2006 May; 36(5):333-9. PubMed ID: 16634837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of a common methylenetetrahydrofolate reductase mutation on levels of homocysteine, folate, vitamin B12 and on the risk of premature atherosclerosis.
    Verhoeff BJ; Trip MD; Prins MH; Kastelein JJ; Reitsma PH
    Atherosclerosis; 1998 Nov; 141(1):161-6. PubMed ID: 9863549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homocysteine and cardiovascular disease.
    Refsum H; Ueland PM; Nygård O; Vollset SE
    Annu Rev Med; 1998; 49():31-62. PubMed ID: 9509248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folic acid with or without vitamin B12 for cognition and dementia.
    Malouf M; Grimley EJ; Areosa SA
    Cochrane Database Syst Rev; 2003; (4):CD004514. PubMed ID: 14584018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.